#irak4 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #irak4, aggregated by home.social.
-
Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration
First-in-human Phase 1 trial evaluating KT-485 (SAR447971) initiated, triggering a $20 million milesto…
#France #FR #Europe #EU #Sanofi #1 #Achievement #and #Announces #collaboration #Degrader #Dosed #first #in #IRAK4 #KT-485 #Kymera #Milestone #of #Oral #Participant #Phase #Therapeutics #trial #under
https://www.europesays.com/france/33037/